| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Branding > The Trust Issue In Marketing |
|
Advice You - The Trust Issue In Marketing
One of the prime motivating factors in the purchase decision making process is “trust”. A consumer will at some According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product point for however long or short of a time, ask the question, “Can I trust this company/person/product?” In tod ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ay’s ever-changing world of marketing, electronic media, email, and advertising innovations and intrusions, comp lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. anies, and businesses are marketing to an ever increasingly suspicious consumer, who is conflicted between their here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe desire not to be “sold” to and their desire to consume. They are looking for ways to establish believability, d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro credibility, and trust. According to a paper by the Peppers and Rogers Group (2004), 36% of major U.S. corporat ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ions view privacy as an important part of the company’s brand image. It is my belief based on consumer thinking easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi that one way to develop a competitive edge in the marketing world is to place greater emphasis on tying privacy nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically policy to brand. This strategy places a direct link between trust and purchase while developing the beginnings and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ of long-term relationship. I suggest highlighting your privacy policy in all your marketing in a way that makes ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi privacy, trust, and your brand synonymous. Let the consumer know that here is a business that will respect you ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a r privacy. Let them know that your communication with them will be relevant to their consumer needs. And you ca dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod n let them know that information they share with your business will be used to better meet their needs and will cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin not, knowingly be used against them, sold, or given to third parties. It might even be smart to develop a short tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen marketing campaign that focuses on your commitment to your customer’s privacy, instead of simply stating that yo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel u have a privacy policy or stating your policy in unreadable font at the bottom of your literature. About 50 % ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust of consumers today have little more knowledge than brand or product recognition and have little desire to acquir y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e extra information about a brand or product, so it behooves the marketing community to link recognition of thei . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r brand to trust, safety, and advocacy. Instead of selling to consumers, target your marketing to help them bel elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ieve that you are making them safer and more secure by purchasing your brand and then back it up! copyright 200 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Great Tips To Help You Find Products To Sell 10-Day Rule For Franchise Sales; Cooling Off Period
|